المؤلفون: S, Eldershaw, K, Verma, W, Croft, T, Rai, FAM, Kinsella, C, Stephens, H, Chen, J, Nunnick, J, Zuo, R, Malladi, P, Moss

المصدر: In iScience 19 March 2021 24(3)

المؤلفون: Shaw KL; Centre for Patient Reported Outcomes Research, Institute of Applied Health Research, University of Birmingham, Birmingham B15 2TT, UK; NIHR Blood and Transplant Research Unit in Precision Cellular Therapeutics, Birmingham, UK., Calvert MJ; Centre for Patient Reported Outcomes Research, Institute of Applied Health Research, University of Birmingham, Birmingham B15 2TT, UK; NIHR Blood and Transplant Research Unit in Precision Cellular Therapeutics, Birmingham, UK; NIHR Birmingham Biomedical Research Centre, University of Birmingham, Birmingham, UK; Birmingham Health Partners Centre for Regulatory Science and Innovation, University of Birmingham, Birmingham, UK; NIHR Applied Research Collaboration West Midlands, University of Birmingham, Birmingham, UK., Borrow P; NIHR Blood and Transplant Research Unit in Precision Cellular Therapeutics, Birmingham, UK; Centre for Immuno-Oncology, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, UK., Chakera E; Birmingham, UK., Chakraverty R; NIHR Blood and Transplant Research Unit in Precision Cellular Therapeutics, Birmingham, UK; MRC Molecular Haematology Unit, MRC Weatherall Institute of Molecular Medicine, Radcliffe Department of Medicine, University of Oxford, Oxford, UK; Oxford National Institute of Health Research Biomedical Research Centre, University of Oxford, Oxford, UK., Hughes SE; Centre for Patient Reported Outcomes Research, Institute of Applied Health Research, University of Birmingham, Birmingham B15 2TT, UK; NIHR Blood and Transplant Research Unit in Precision Cellular Therapeutics, Birmingham, UK; Birmingham Health Partners Centre for Regulatory Science and Innovation, University of Birmingham, Birmingham, UK; NIHR Applied Research Collaboration West Midlands, University of Birmingham, Birmingham, UK., Khatsuria F; Centre for Patient Reported Outcomes Research, Institute of Applied Health Research, University of Birmingham, Birmingham B15 2TT, UK; NIHR Blood and Transplant Research Unit in Precision Cellular Therapeutics, Birmingham, UK; NIHR Birmingham Biomedical Research Centre, University of Birmingham, Birmingham, UK., Kinsella FAM; NIHR Birmingham Biomedical Research Centre, University of Birmingham, Birmingham, UK; Birmingham Centre for Cellular Therapy and Transplantation, University Hospitals Birmingham NHS Trust, Birmingham, UK., McMullan C; Centre for Patient Reported Outcomes Research, Institute of Applied Health Research, University of Birmingham, Birmingham B15 2TT, UK; NIHR Blood and Transplant Research Unit in Precision Cellular Therapeutics, Birmingham, UK., Richardson-Abraham J; Birmingham, UK., Yarosh V; NIHR Blood and Transplant Research Unit in Precision Cellular Therapeutics, Birmingham, UK; Translational Research Office, Medical Sciences Division, University of Oxford, Oxford, UK., Aiyegbusi OL; Centre for Patient Reported Outcomes Research, Institute of Applied Health Research, University of Birmingham, Birmingham B15 2TT, UK; NIHR Blood and Transplant Research Unit in Precision Cellular Therapeutics, Birmingham, UK; NIHR Birmingham Biomedical Research Centre, University of Birmingham, Birmingham, UK; Birmingham Health Partners Centre for Regulatory Science and Innovation, University of Birmingham, Birmingham, UK; NIHR Applied Research Collaboration West Midlands, University of Birmingham, Birmingham, UK. Electronic address: o.l.aiyegbusi@bham.ac.uk.

المصدر: Lancet (London, England) [Lancet] 2024 Aug 08. Date of Electronic Publication: 2024 Aug 08.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Elsevier Country of Publication: England NLM ID: 2985213R Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1474-547X (Electronic) Linking ISSN: 01406736 NLM ISO Abbreviation: Lancet Subsets: MEDLINE

المؤلفون: Farhat M; Institute of Immunology and Immunotherapy, College of Medical and Dental Sciences, University of Birmingham, Birmingham, B15 2TT, UK., Croft W; Institute of Immunology and Immunotherapy, College of Medical and Dental Sciences, University of Birmingham, Birmingham, B15 2TT, UK., Parry HM; Institute of Immunology and Immunotherapy, College of Medical and Dental Sciences, University of Birmingham, Birmingham, B15 2TT, UK.; University Hospitals Birmingham NHS Foundation Trust, Queen Elizabeth Hospital Birmingham, Mindelsohn Way, Edgbaston, Birmingham, B15 2GW, UK., Verma K; Institute of Immunology and Immunotherapy, College of Medical and Dental Sciences, University of Birmingham, Birmingham, B15 2TT, UK., Kinsella FAM; University Hospitals Birmingham NHS Foundation Trust, Queen Elizabeth Hospital Birmingham, Mindelsohn Way, Edgbaston, Birmingham, B15 2GW, UK., Xu J; Institute of Immunology and Immunotherapy, College of Medical and Dental Sciences, University of Birmingham, Birmingham, B15 2TT, UK., Bone D; Institute of Immunology and Immunotherapy, College of Medical and Dental Sciences, University of Birmingham, Birmingham, B15 2TT, UK., McSkeane T; University Hospitals Birmingham NHS Foundation Trust, Queen Elizabeth Hospital Birmingham, Mindelsohn Way, Edgbaston, Birmingham, B15 2GW, UK., Paneesha S; Birmingham Heartlands Hospital, University Hospitals Birmingham, Birmingham, B9 5SS, UK., Pratt G; University Hospitals Birmingham NHS Foundation Trust, Queen Elizabeth Hospital Birmingham, Mindelsohn Way, Edgbaston, Birmingham, B15 2GW, UK., Moss P; Institute of Immunology and Immunotherapy, College of Medical and Dental Sciences, University of Birmingham, Birmingham, B15 2TT, UK.; University Hospitals Birmingham NHS Foundation Trust, Queen Elizabeth Hospital Birmingham, Mindelsohn Way, Edgbaston, Birmingham, B15 2GW, UK., Zuo J; Institute of Immunology and Immunotherapy, College of Medical and Dental Sciences, University of Birmingham, Birmingham, B15 2TT, UK. j.zuo@bham.ac.uk.

المصدر: Leukemia [Leukemia] 2024 Aug; Vol. 38 (8), pp. 1813-1817. Date of Electronic Publication: 2024 May 09.

نوع المنشور: Letter; Journal Article

بيانات الدورية: Publisher: Nature Publishing Group, Specialist Journals Country of Publication: England NLM ID: 8704895 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5551 (Electronic) Linking ISSN: 08876924 NLM ISO Abbreviation: Leukemia Subsets: MEDLINE

مواضيع طبية MeSH: Killer Cells, Natural*/immunology , Killer Cells, Natural*/metabolism , Programmed Cell Death 1 Receptor*/metabolism , Leukemia, Lymphocytic, Chronic, B-Cell*/metabolism , Leukemia, Lymphocytic, Chronic, B-Cell*/pathology , Leukemia, Lymphocytic, Chronic, B-Cell*/immunology, Humans

المؤلفون: Pradana F; School of Sport, Exercise, and Rehabilitation Sciences, University of Birmingham, Birmingham, United Kingdom.; Nutrition Study Program, Faculty of Public Health, Tadulako University, Palu, Indonesia., Nijjar T; School of Sport, Exercise, and Rehabilitation Sciences, University of Birmingham, Birmingham, United Kingdom., Cox PA; School of Sport, Exercise, and Rehabilitation Sciences, University of Birmingham, Birmingham, United Kingdom., Morgan PT; School of Sport, Exercise, and Rehabilitation Sciences, University of Birmingham, Birmingham, United Kingdom.; Department of Sport and Exercise Sciences, Manchester Metropolitan University, Manchester, United Kingdom., Podlogar T; School of Sport, Exercise, and Rehabilitation Sciences, University of Birmingham, Birmingham, United Kingdom., Lucas SJE; School of Sport, Exercise, and Rehabilitation Sciences, University of Birmingham, Birmingham, United Kingdom., Drayson MT; Clinical Immunology Service, University of Birmingham, Birmingham, United Kingdom., Kinsella FAM; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, United Kingdom.; Centre for Clinical Haematology, Queen Elizabeth Hospital, Birmingham, United Kingdom., Wadley AJ; School of Sport, Exercise, and Rehabilitation Sciences, University of Birmingham, Birmingham, United Kingdom.

المصدر: Frontiers in physiology [Front Physiol] 2024 Jul 30; Vol. 15, pp. 1327269. Date of Electronic Publication: 2024 Jul 30 (Print Publication: 2024).

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Frontiers Research Foundation Country of Publication: Switzerland NLM ID: 101549006 Publication Model: eCollection Cited Medium: Print ISSN: 1664-042X (Print) Linking ISSN: 1664042X NLM ISO Abbreviation: Front Physiol Subsets: PubMed not MEDLINE

المؤلفون: Verma K; University of Birmingham, Birmingham, United Kingdom., Croft W; University of Birmingham, Birmingham, United Kingdom., Margielewska-Davies S; University of Birmingham, Birmingham, United Kingdom., Pearce H; University of Birmingham, Birmingham, United Kingdom., Stephens C; University of Birmingham, Birmingham, United Kingdom., Diaconescu D; University of Birmingham, Birmingham, United Kingdom., Bevington S; University of Birmingham, Birmingham, United Kingdom., Craddock C; Warwick Clinical Trials Unit, Warwick University, United Kingdom., Amel-Kashipaz R; Queen Elizabeth Hospital, United Kingdom., Zuo JJ; University of Birmingham, United Kingdom., Kinsella FAM; Queen Elizabeth Hospital, United Kingdom., Moss P; University of Birmingham, Birmingham, United Kingdom.

المصدر: Blood advances [Blood Adv] 2024 Jul 19. Date of Electronic Publication: 2024 Jul 19.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: American Society of Hematology Country of Publication: United States NLM ID: 101698425 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2473-9537 (Electronic) Linking ISSN: 24739529 NLM ISO Abbreviation: Blood Adv Subsets: MEDLINE

المؤلفون: Kinsella FAM; Centre for Clinical Haematology, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.; University of Birmingham College of Medical and Dental Sciences, Birmingham, UK., Maroto MAL; Centre for Clinical Haematology, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK., Loke J; Centre for Clinical Haematology, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.; University of Birmingham College of Medical and Dental Sciences, Birmingham, UK., Craddock C; Centre for Clinical Haematology, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.; Clinical Trials Unit, University of Warwick, Warwick, UK.

المصدر: British journal of haematology [Br J Haematol] 2024 Jun; Vol. 204 (6), pp. 2173-2183. Date of Electronic Publication: 2024 Apr 11.

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 0372544 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2141 (Electronic) Linking ISSN: 00071048 NLM ISO Abbreviation: Br J Haematol Subsets: MEDLINE

مواضيع طبية MeSH: Leukemia, Myeloid, Acute*/therapy , Hematopoietic Stem Cell Transplantation*/methods , Transplantation, Homologous*, Humans ; Recurrence ; Graft vs Leukemia Effect ; Neoplasm, Residual

المؤلفون: Verma K; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, United Kingdom., Croft W; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, United Kingdom.; Centre for Computational Biology, University of Birmingham, Birmingham, United Kingdom., Greenwood D; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, United Kingdom.; Centre for Computational Biology, University of Birmingham, Birmingham, United Kingdom., Stephens C; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, United Kingdom., Malladi R; Centre for Clinical Haematology, Queen Elizabeth Hospital, Birmingham, United Kingdom., Nunnick J; Centre for Clinical Haematology, Queen Elizabeth Hospital, Birmingham, United Kingdom., Zuo J; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, United Kingdom., Kinsella FAM; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, United Kingdom.; Centre for Clinical Haematology, Queen Elizabeth Hospital, Birmingham, United Kingdom., Moss P; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, United Kingdom.; Centre for Clinical Haematology, Queen Elizabeth Hospital, Birmingham, United Kingdom.

المصدر: Frontiers in immunology [Front Immunol] 2024 Jan 03; Vol. 14, pp. 1332777. Date of Electronic Publication: 2024 Jan 03 (Print Publication: 2023).

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE

مواضيع طبية MeSH: Hematopoietic Stem Cell Transplantation*/adverse effects , Graft vs Host Disease*, Humans ; Prognosis ; Transplantation, Homologous/adverse effects ; Neoplasm Recurrence, Local/complications ; Chronic Disease ; Recurrence

المؤلفون: Parry HM; Institute of Immunology & Immunotherapy, College of Medical and Dental Sciences, University of Birmingham, Birmingham, United Kingdom., Dowell AC; Institute of Immunology & Immunotherapy, College of Medical and Dental Sciences, University of Birmingham, Birmingham, United Kingdom., Zuo J; Institute of Immunology & Immunotherapy, College of Medical and Dental Sciences, University of Birmingham, Birmingham, United Kingdom., Verma K; Institute of Immunology & Immunotherapy, College of Medical and Dental Sciences, University of Birmingham, Birmingham, United Kingdom., Kinsella FAM; Institute of Immunology & Immunotherapy, College of Medical and Dental Sciences, University of Birmingham, Birmingham, United Kingdom., Begum J; Institute of Immunology & Immunotherapy, College of Medical and Dental Sciences, University of Birmingham, Birmingham, United Kingdom., Croft W; Institute of Immunology & Immunotherapy, College of Medical and Dental Sciences, University of Birmingham, Birmingham, United Kingdom.; Centre for Computational Biology, College of Medical and Dental Sciences, University of Birmingham, Birmingham, United Kingdom., Sharma-Oates A; Centre for Computational Biology, College of Medical and Dental Sciences, University of Birmingham, Birmingham, United Kingdom.; Institute of Cancer & Genomics, College of Medical and Dental Sciences, University of Birmingham, Birmingham, United Kingdom., Pratt G; Institute of Immunology & Immunotherapy, College of Medical and Dental Sciences, University of Birmingham, Birmingham, United Kingdom.; Queen Elizabeth Hospital, University Hospitals Birmingham NHS Foundation Trust, Birmingham, United Kingdom., Moss P; Institute of Immunology & Immunotherapy, College of Medical and Dental Sciences, University of Birmingham, Birmingham, United Kingdom.

المصدر: PLoS pathogens [PLoS Pathog] 2021 Mar 04; Vol. 17 (3), pp. e1009349. Date of Electronic Publication: 2021 Mar 04 (Print Publication: 2021).

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Public Library of Science Country of Publication: United States NLM ID: 101238921 Publication Model: eCollection Cited Medium: Internet ISSN: 1553-7374 (Electronic) Linking ISSN: 15537366 NLM ISO Abbreviation: PLoS Pathog Subsets: MEDLINE

مواضيع طبية MeSH: CD4-Positive T-Lymphocytes/*metabolism , Cytokines/*metabolism , Cytomegalovirus/*pathogenicity , Cytomegalovirus Infections/*virology , Programmed Cell Death 1 Receptor/*metabolism, CD4-Positive T-Lymphocytes/immunology ; CD8-Positive T-Lymphocytes/immunology ; CD8-Positive T-Lymphocytes/metabolism ; Cytokines/immunology ; Cytomegalovirus/metabolism ; Cytomegalovirus Infections/immunology ; Gene Expression/immunology ; Humans ; Programmed Cell Death 1 Receptor/immunology ; Viral Load/immunology

المؤلفون: Kinsella FAM; UK Photopheresis Society, Birmingham, Rotherham, Newcastle, Leeds, Sheffield, UK., Bencito A; UK Photopheresis Society, Birmingham, Rotherham, Newcastle, Leeds, Sheffield, UK., Kulik D; UK Photopheresis Society, Birmingham, Rotherham, Newcastle, Leeds, Sheffield, UK., Hurst E; UK Photopheresis Society, Birmingham, Rotherham, Newcastle, Leeds, Sheffield, UK., Gilleece M; UK Photopheresis Society, Birmingham, Rotherham, Newcastle, Leeds, Sheffield, UK., Snowden JA; UK Photopheresis Society, Birmingham, Rotherham, Newcastle, Leeds, Sheffield, UK., Malladi R; UK Photopheresis Society, Birmingham, Rotherham, Newcastle, Leeds, Sheffield, UK., Scarisbrick J; UK Photopheresis Society, Birmingham, Rotherham, Newcastle, Leeds, Sheffield, UK., Gennery A; UK Photopheresis Society, Birmingham, Rotherham, Newcastle, Leeds, Sheffield, UK., Alfred A; UK Photopheresis Society, Birmingham, Rotherham, Newcastle, Leeds, Sheffield, UK.

المصدر: Leukemia & lymphoma [Leuk Lymphoma] 2020 Dec; Vol. 61 (14), pp. 3511-3514. Date of Electronic Publication: 2020 Sep 02.

نوع المنشور: Letter

بيانات الدورية: Publisher: Taylor & Francis Country of Publication: United States NLM ID: 9007422 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1029-2403 (Electronic) Linking ISSN: 10268022 NLM ISO Abbreviation: Leuk Lymphoma Subsets: MEDLINE

مواضيع طبية MeSH: Graft vs Host Disease*/etiology , Graft vs Host Disease*/therapy , Hematopoietic Stem Cell Transplantation* , Photopheresis*, Chronic Disease ; Humans ; United Kingdom

المؤلفون: Kinsella FAM; School of Cancer Sciences, University of Birmingham, Birmingham, UK; Centre for Clinical Haematology, Queen Elizabeth NHS Foundation Trust, Birmingham, UK., Inman CF; School of Cancer Sciences, University of Birmingham, Birmingham, UK., Gudger A; Heartlands Hospital, Heart of England NHS Foundation trust, Birmingham, UK., Chan YT; School of Cancer Sciences, University of Birmingham, Birmingham, UK., Murray DJ; School of Cancer Sciences, University of Birmingham, Birmingham, UK., Zuo J; School of Cancer Sciences, University of Birmingham, Birmingham, UK., McIlroy G; Centre for Clinical Haematology, Queen Elizabeth NHS Foundation Trust, Birmingham, UK., Nagra S; Centre for Clinical Haematology, Queen Elizabeth NHS Foundation Trust, Birmingham, UK., Nunnick J; Centre for Clinical Haematology, Queen Elizabeth NHS Foundation Trust, Birmingham, UK., Holder K; Heartlands Hospital, Heart of England NHS Foundation trust, Birmingham, UK., Wall K; West Midlands Regional Genetics Laboratory, Birmingham Women's NHS Foundation Trust, Birmingham, UK., Griffiths M; School of Cancer Sciences, University of Birmingham, Birmingham, UK; West Midlands Regional Genetics Laboratory, Birmingham Women's NHS Foundation Trust, Birmingham, UK., Craddock C; Centre for Clinical Haematology, Queen Elizabeth NHS Foundation Trust, Birmingham, UK., Nikolousis E; Heartlands Hospital, Heart of England NHS Foundation trust, Birmingham, UK., Moss P; School of Cancer Sciences, University of Birmingham, Birmingham, UK; Centre for Clinical Haematology, Queen Elizabeth NHS Foundation Trust, Birmingham, UK. Electronic address: p.moss@bham.ac.uk., Malladi R; School of Cancer Sciences, University of Birmingham, Birmingham, UK; Centre for Clinical Haematology, Queen Elizabeth NHS Foundation Trust, Birmingham, UK.

المصدر: Leukemia research [Leuk Res] 2019 Aug; Vol. 83, pp. 106173. Date of Electronic Publication: 2019 Jun 18.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Pergamon Press Country of Publication: England NLM ID: 7706787 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-5835 (Electronic) Linking ISSN: 01452126 NLM ISO Abbreviation: Leuk Res Subsets: MEDLINE

مواضيع طبية MeSH: Hematopoietic Stem Cell Transplantation* , Leukemia, Myeloid, Acute*/blood , Leukemia, Myeloid, Acute*/mortality , Leukemia, Myeloid, Acute*/therapy , Lymphoma*/blood , Lymphoma*/mortality , Lymphoma*/therapy , Myelodysplastic Syndromes*/blood , Myelodysplastic Syndromes*/mortality , Myelodysplastic Syndromes*/therapy, T-Lymphocytes/*metabolism , Transplantation Chimera/*blood, Adult ; Aged ; Allografts ; Disease-Free Survival ; Female ; Humans ; Male ; Middle Aged ; Survival Rate